<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="T2" orientation="portrait" position="float">
 <label>Table 2.</label>
 <caption>
  <p>Demographic, Laboratory, and Clinical Characteristics</p>
 </caption>
 <table frame="vsides" rules="groups">
  <thead>
   <tr>
    <th align="left" valign="bottom" rowspan="1" colspan="1">Chararacteristic</th>
    <th align="center" valign="bottom" rowspan="1" colspan="1">Patients, No. (%)
     <sup>a</sup> (n = 53)
    </th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td rowspan="1" colspan="1">Demographics</td>
    <td align="center" rowspan="1" colspan="1"/>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Age, median (IQR), y</td>
    <td rowspan="1" colspan="1">45 (30–74)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Male sex</td>
    <td rowspan="1" colspan="1">39 (74)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Race</td>
    <td align="center" rowspan="1" colspan="1"/>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">  Asian</td>
    <td rowspan="1" colspan="1">2 (4)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">  Black</td>
    <td rowspan="1" colspan="1">1 (2)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">  Native American</td>
    <td rowspan="1" colspan="1">1 (2)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">  White</td>
    <td rowspan="1" colspan="1">43 (81)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">  Refused/unknown</td>
    <td rowspan="1" colspan="1">6 (11)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Disease status</td>
    <td align="center" rowspan="1" colspan="1"/>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Prior lines of therapy, median (IQR)</td>
    <td rowspan="1" colspan="1">3 (2–7)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Relapse after HSCT</td>
    <td rowspan="1" colspan="1">19 (36)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Hematologic parameters before CTI</td>
    <td align="center" rowspan="1" colspan="1"/>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> ALC &lt;300 cells/µL</td>
    <td rowspan="1" colspan="1">30 (57)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Lymphopenia duration, median (IQR), d</td>
    <td rowspan="1" colspan="1">3 (1–42)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> ANC &lt;500 cells/µL</td>
    <td rowspan="1" colspan="1">18 (34)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Neutropenia duration, median (IQR), d</td>
    <td rowspan="1" colspan="1">12 (3–83)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Hematologic parameters on day of CTI</td>
    <td align="center" rowspan="1" colspan="1"/>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> ALC &lt;300 cells/µL</td>
    <td rowspan="1" colspan="1">31 (58)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> ANC &lt;500 cells/µL</td>
    <td rowspan="1" colspan="1">23 (43)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Antimicrobial prophylaxis before CTI</td>
    <td align="center" rowspan="1" colspan="1"/>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Antibacterial prophylaxis</td>
    <td rowspan="1" colspan="1">0 (0)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Antifungal prophylaxis</td>
    <td align="center" rowspan="1" colspan="1"/>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">  Micafungin</td>
    <td rowspan="1" colspan="1">32 (60)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">  Fluconazole</td>
    <td rowspan="1" colspan="1">1 (2)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">  Posaconazole</td>
    <td rowspan="1" colspan="1">3 (6)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">  Voriconazole</td>
    <td rowspan="1" colspan="1">6 (11)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">  None</td>
    <td rowspan="1" colspan="1">11 (21)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Anti-
     <italic>Pneumocystis</italic> prophylaxis
    </td>
    <td align="center" rowspan="1" colspan="1"/>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">  Atovaquone</td>
    <td rowspan="1" colspan="1">2 (4)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">  Dapsone</td>
    <td rowspan="1" colspan="1">3 (6)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">  Pentamidine</td>
    <td rowspan="1" colspan="1">9 (17)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">  Trimethoprim-sulfamethoxazole</td>
    <td rowspan="1" colspan="1">32 (60)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">  None</td>
    <td rowspan="1" colspan="1">7 (13)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Antiviral prophylaxis</td>
    <td align="center" rowspan="1" colspan="1"/>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">  Acyclovir</td>
    <td rowspan="1" colspan="1">38 (72)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">  Famciclovir</td>
    <td rowspan="1" colspan="1">1 (2)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">  Valacyclovir</td>
    <td rowspan="1" colspan="1">11 (21)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">  Valganciclovir</td>
    <td rowspan="1" colspan="1">2 (4)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">  None</td>
    <td rowspan="1" colspan="1">1 (2)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Cytokine release syndrome</td>
    <td align="center" rowspan="1" colspan="1"/>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Grade 0</td>
    <td rowspan="1" colspan="1">8 (15)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Grade 1–2</td>
    <td rowspan="1" colspan="1">31 (59)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Grade 3–5</td>
    <td rowspan="1" colspan="1">14 (26)</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn id="fn-01">
   <p>Abbreviations: ALC, absolute lymphocyte count; ANC, absolute neutrophil count; CTI, chimeric antigen receptor T-cell infusion; HSCT, hematopoietic stem cell transplantation; IQR, interquartile range.</p>
  </fn>
  <fn id="fn-02">
   <p>
    <sup>a</sup>Data represent No. (%) of patients unless otherwise identified as median (IQR).
   </p>
  </fn>
 </table-wrap-foot>
</table-wrap>
